ONCOL REP 润色咨询

ONCOLOGY REPORTS

出版年份：1994 年文章数：5979 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：5.3% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=534017, encodeId=b8a453401ed7, content=还是问问吧<span class="quote">liyarui 2017-02-21 发表::<br>修了图片等了快一个月了也没有回复，能不能发邮件问一下</span>, beContent=liyarui 2017-02-21 发表:: 修了图片等了快一个月了也没有回复，能不能发邮件问一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Fri Mar 10 23:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533649, encodeId=b8dd5336497a, content=请问关于天然产物对肝癌细胞的抑制作用的文章可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb781996655, createdName=蓝莓花青素, createdTime=Thu Mar 02 21:07:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533156, encodeId=3dce5331563b, content=修了图片等了快一个月了也没有回复，能不能发邮件问一下<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3c485caee58448a74e2f8e0e8cd4a710.jpg, createdBy=f4421981394, createdName=lary, createdTime=Tue Feb 21 21:51:00 CST 2017, time=2017-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533070, encodeId=cdb55330e047, content=您好 请问修改后的稿件要怎么投出去？<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533069, encodeId=6ef353306939, content=您好 请问修改后的稿件怎么投出去？邮件么？<span class="quote">Dr.Q 2017-02-08 发表::<br>接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。</span>, beContent=Dr.Q 2017-02-08 发表:: 接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532807, encodeId=24aa53280e1a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86979398, createdName=jerryraincy, createdTime=Tue Feb 14 13:51:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532578, encodeId=a7125325e8e7, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e581988587, createdName=Dr.Q, createdTime=Wed Feb 08 11:13:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532564, encodeId=58ad5325643e, content=请问<span class="quote">独孤九剑 2017-02-04 发表::<br>不收病例报道</span>, beContent=独孤九剑 2017-02-04 发表:: 不收病例报道, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/27/5c1c28f375e458734b074bfcd8876252.jpg, createdBy=c3fa2014320, createdName=TanTXiangS, createdTime=Tue Feb 07 22:35:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532467, encodeId=989d53246e19, content=不收病例报道<span class="quote">langlangzhou 2017-02-03 发表::<br>各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式</span>, beContent=langlangzhou 2017-02-03 发表:: 各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ede81680471, createdName=独孤九剑, createdTime=Sat Feb 04 14:15:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532416, encodeId=f582532416a5, content=各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce51994062, createdName=langlangzhou, createdTime=Fri Feb 03 09:13:00 CST 2017, time=2017-02-03, status=1, ipAttribution=)]
    2017-03-10 sugar661930

    还是问问吧liyarui 2017-02-21 发表::
    修了图片等了快一个月了也没有回复，能不能发邮件问一下

    liyarui 2017-02-21 发表:: 修了图片等了快一个月了也没有回复，能不能发邮件问一下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=534017, encodeId=b8a453401ed7, content=还是问问吧<span class="quote">liyarui 2017-02-21 发表::<br>修了图片等了快一个月了也没有回复，能不能发邮件问一下</span>, beContent=liyarui 2017-02-21 发表:: 修了图片等了快一个月了也没有回复，能不能发邮件问一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Fri Mar 10 23:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533649, encodeId=b8dd5336497a, content=请问关于天然产物对肝癌细胞的抑制作用的文章可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb781996655, createdName=蓝莓花青素, createdTime=Thu Mar 02 21:07:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533156, encodeId=3dce5331563b, content=修了图片等了快一个月了也没有回复，能不能发邮件问一下<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3c485caee58448a74e2f8e0e8cd4a710.jpg, createdBy=f4421981394, createdName=lary, createdTime=Tue Feb 21 21:51:00 CST 2017, time=2017-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533070, encodeId=cdb55330e047, content=您好 请问修改后的稿件要怎么投出去？<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533069, encodeId=6ef353306939, content=您好 请问修改后的稿件怎么投出去？邮件么？<span class="quote">Dr.Q 2017-02-08 发表::<br>接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。</span>, beContent=Dr.Q 2017-02-08 发表:: 接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532807, encodeId=24aa53280e1a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86979398, createdName=jerryraincy, createdTime=Tue Feb 14 13:51:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532578, encodeId=a7125325e8e7, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e581988587, createdName=Dr.Q, createdTime=Wed Feb 08 11:13:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532564, encodeId=58ad5325643e, content=请问<span class="quote">独孤九剑 2017-02-04 发表::<br>不收病例报道</span>, beContent=独孤九剑 2017-02-04 发表:: 不收病例报道, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/27/5c1c28f375e458734b074bfcd8876252.jpg, createdBy=c3fa2014320, createdName=TanTXiangS, createdTime=Tue Feb 07 22:35:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532467, encodeId=989d53246e19, content=不收病例报道<span class="quote">langlangzhou 2017-02-03 发表::<br>各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式</span>, beContent=langlangzhou 2017-02-03 发表:: 各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ede81680471, createdName=独孤九剑, createdTime=Sat Feb 04 14:15:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532416, encodeId=f582532416a5, content=各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce51994062, createdName=langlangzhou, createdTime=Fri Feb 03 09:13:00 CST 2017, time=2017-02-03, status=1, ipAttribution=)]
    2017-03-02 蓝莓花青素

    请问关于天然产物对肝癌细胞的抑制作用的文章可以投吗

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=534017, encodeId=b8a453401ed7, content=还是问问吧<span class="quote">liyarui 2017-02-21 发表::<br>修了图片等了快一个月了也没有回复，能不能发邮件问一下</span>, beContent=liyarui 2017-02-21 发表:: 修了图片等了快一个月了也没有回复，能不能发邮件问一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Fri Mar 10 23:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533649, encodeId=b8dd5336497a, content=请问关于天然产物对肝癌细胞的抑制作用的文章可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb781996655, createdName=蓝莓花青素, createdTime=Thu Mar 02 21:07:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533156, encodeId=3dce5331563b, content=修了图片等了快一个月了也没有回复，能不能发邮件问一下<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3c485caee58448a74e2f8e0e8cd4a710.jpg, createdBy=f4421981394, createdName=lary, createdTime=Tue Feb 21 21:51:00 CST 2017, time=2017-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533070, encodeId=cdb55330e047, content=您好 请问修改后的稿件要怎么投出去？<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533069, encodeId=6ef353306939, content=您好 请问修改后的稿件怎么投出去？邮件么？<span class="quote">Dr.Q 2017-02-08 发表::<br>接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。</span>, beContent=Dr.Q 2017-02-08 发表:: 接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532807, encodeId=24aa53280e1a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86979398, createdName=jerryraincy, createdTime=Tue Feb 14 13:51:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532578, encodeId=a7125325e8e7, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e581988587, createdName=Dr.Q, createdTime=Wed Feb 08 11:13:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532564, encodeId=58ad5325643e, content=请问<span class="quote">独孤九剑 2017-02-04 发表::<br>不收病例报道</span>, beContent=独孤九剑 2017-02-04 发表:: 不收病例报道, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/27/5c1c28f375e458734b074bfcd8876252.jpg, createdBy=c3fa2014320, createdName=TanTXiangS, createdTime=Tue Feb 07 22:35:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532467, encodeId=989d53246e19, content=不收病例报道<span class="quote">langlangzhou 2017-02-03 发表::<br>各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式</span>, beContent=langlangzhou 2017-02-03 发表:: 各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ede81680471, createdName=独孤九剑, createdTime=Sat Feb 04 14:15:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532416, encodeId=f582532416a5, content=各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce51994062, createdName=langlangzhou, createdTime=Fri Feb 03 09:13:00 CST 2017, time=2017-02-03, status=1, ipAttribution=)]
    2017-02-21 lary

    修了图片等了快一个月了也没有回复，能不能发邮件问一下jerryraincy 2017-02-14 发表::
    研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。

    jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=534017, encodeId=b8a453401ed7, content=还是问问吧<span class="quote">liyarui 2017-02-21 发表::<br>修了图片等了快一个月了也没有回复，能不能发邮件问一下</span>, beContent=liyarui 2017-02-21 发表:: 修了图片等了快一个月了也没有回复，能不能发邮件问一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Fri Mar 10 23:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533649, encodeId=b8dd5336497a, content=请问关于天然产物对肝癌细胞的抑制作用的文章可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb781996655, createdName=蓝莓花青素, createdTime=Thu Mar 02 21:07:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533156, encodeId=3dce5331563b, content=修了图片等了快一个月了也没有回复，能不能发邮件问一下<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3c485caee58448a74e2f8e0e8cd4a710.jpg, createdBy=f4421981394, createdName=lary, createdTime=Tue Feb 21 21:51:00 CST 2017, time=2017-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533070, encodeId=cdb55330e047, content=您好 请问修改后的稿件要怎么投出去？<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533069, encodeId=6ef353306939, content=您好 请问修改后的稿件怎么投出去？邮件么？<span class="quote">Dr.Q 2017-02-08 发表::<br>接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。</span>, beContent=Dr.Q 2017-02-08 发表:: 接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532807, encodeId=24aa53280e1a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86979398, createdName=jerryraincy, createdTime=Tue Feb 14 13:51:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532578, encodeId=a7125325e8e7, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e581988587, createdName=Dr.Q, createdTime=Wed Feb 08 11:13:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532564, encodeId=58ad5325643e, content=请问<span class="quote">独孤九剑 2017-02-04 发表::<br>不收病例报道</span>, beContent=独孤九剑 2017-02-04 发表:: 不收病例报道, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/27/5c1c28f375e458734b074bfcd8876252.jpg, createdBy=c3fa2014320, createdName=TanTXiangS, createdTime=Tue Feb 07 22:35:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532467, encodeId=989d53246e19, content=不收病例报道<span class="quote">langlangzhou 2017-02-03 发表::<br>各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式</span>, beContent=langlangzhou 2017-02-03 发表:: 各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ede81680471, createdName=独孤九剑, createdTime=Sat Feb 04 14:15:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532416, encodeId=f582532416a5, content=各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce51994062, createdName=langlangzhou, createdTime=Fri Feb 03 09:13:00 CST 2017, time=2017-02-03, status=1, ipAttribution=)]
    2017-02-20 sugar661930

    您好 请问修改后的稿件要怎么投出去？jerryraincy 2017-02-14 发表::
    研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。

    jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=534017, encodeId=b8a453401ed7, content=还是问问吧<span class="quote">liyarui 2017-02-21 发表::<br>修了图片等了快一个月了也没有回复，能不能发邮件问一下</span>, beContent=liyarui 2017-02-21 发表:: 修了图片等了快一个月了也没有回复，能不能发邮件问一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Fri Mar 10 23:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533649, encodeId=b8dd5336497a, content=请问关于天然产物对肝癌细胞的抑制作用的文章可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb781996655, createdName=蓝莓花青素, createdTime=Thu Mar 02 21:07:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533156, encodeId=3dce5331563b, content=修了图片等了快一个月了也没有回复，能不能发邮件问一下<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3c485caee58448a74e2f8e0e8cd4a710.jpg, createdBy=f4421981394, createdName=lary, createdTime=Tue Feb 21 21:51:00 CST 2017, time=2017-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533070, encodeId=cdb55330e047, content=您好 请问修改后的稿件要怎么投出去？<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533069, encodeId=6ef353306939, content=您好 请问修改后的稿件怎么投出去？邮件么？<span class="quote">Dr.Q 2017-02-08 发表::<br>接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。</span>, beContent=Dr.Q 2017-02-08 发表:: 接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532807, encodeId=24aa53280e1a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86979398, createdName=jerryraincy, createdTime=Tue Feb 14 13:51:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532578, encodeId=a7125325e8e7, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e581988587, createdName=Dr.Q, createdTime=Wed Feb 08 11:13:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532564, encodeId=58ad5325643e, content=请问<span class="quote">独孤九剑 2017-02-04 发表::<br>不收病例报道</span>, beContent=独孤九剑 2017-02-04 发表:: 不收病例报道, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/27/5c1c28f375e458734b074bfcd8876252.jpg, createdBy=c3fa2014320, createdName=TanTXiangS, createdTime=Tue Feb 07 22:35:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532467, encodeId=989d53246e19, content=不收病例报道<span class="quote">langlangzhou 2017-02-03 发表::<br>各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式</span>, beContent=langlangzhou 2017-02-03 发表:: 各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ede81680471, createdName=独孤九剑, createdTime=Sat Feb 04 14:15:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532416, encodeId=f582532416a5, content=各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce51994062, createdName=langlangzhou, createdTime=Fri Feb 03 09:13:00 CST 2017, time=2017-02-03, status=1, ipAttribution=)]
    2017-02-20 sugar661930

    您好 请问修改后的稿件怎么投出去？邮件么？Dr.Q 2017-02-08 发表::
    接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。

    Dr.Q 2017-02-08 发表:: 接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=534017, encodeId=b8a453401ed7, content=还是问问吧<span class="quote">liyarui 2017-02-21 发表::<br>修了图片等了快一个月了也没有回复，能不能发邮件问一下</span>, beContent=liyarui 2017-02-21 发表:: 修了图片等了快一个月了也没有回复，能不能发邮件问一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Fri Mar 10 23:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533649, encodeId=b8dd5336497a, content=请问关于天然产物对肝癌细胞的抑制作用的文章可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb781996655, createdName=蓝莓花青素, createdTime=Thu Mar 02 21:07:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533156, encodeId=3dce5331563b, content=修了图片等了快一个月了也没有回复，能不能发邮件问一下<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3c485caee58448a74e2f8e0e8cd4a710.jpg, createdBy=f4421981394, createdName=lary, createdTime=Tue Feb 21 21:51:00 CST 2017, time=2017-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533070, encodeId=cdb55330e047, content=您好 请问修改后的稿件要怎么投出去？<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533069, encodeId=6ef353306939, content=您好 请问修改后的稿件怎么投出去？邮件么？<span class="quote">Dr.Q 2017-02-08 发表::<br>接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。</span>, beContent=Dr.Q 2017-02-08 发表:: 接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532807, encodeId=24aa53280e1a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86979398, createdName=jerryraincy, createdTime=Tue Feb 14 13:51:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532578, encodeId=a7125325e8e7, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e581988587, createdName=Dr.Q, createdTime=Wed Feb 08 11:13:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532564, encodeId=58ad5325643e, content=请问<span class="quote">独孤九剑 2017-02-04 发表::<br>不收病例报道</span>, beContent=独孤九剑 2017-02-04 发表:: 不收病例报道, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/27/5c1c28f375e458734b074bfcd8876252.jpg, createdBy=c3fa2014320, createdName=TanTXiangS, createdTime=Tue Feb 07 22:35:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532467, encodeId=989d53246e19, content=不收病例报道<span class="quote">langlangzhou 2017-02-03 发表::<br>各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式</span>, beContent=langlangzhou 2017-02-03 发表:: 各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ede81680471, createdName=独孤九剑, createdTime=Sat Feb 04 14:15:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532416, encodeId=f582532416a5, content=各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce51994062, createdName=langlangzhou, createdTime=Fri Feb 03 09:13:00 CST 2017, time=2017-02-03, status=1, ipAttribution=)]
    2017-02-14 jerryraincy

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=534017, encodeId=b8a453401ed7, content=还是问问吧<span class="quote">liyarui 2017-02-21 发表::<br>修了图片等了快一个月了也没有回复，能不能发邮件问一下</span>, beContent=liyarui 2017-02-21 发表:: 修了图片等了快一个月了也没有回复，能不能发邮件问一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Fri Mar 10 23:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533649, encodeId=b8dd5336497a, content=请问关于天然产物对肝癌细胞的抑制作用的文章可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb781996655, createdName=蓝莓花青素, createdTime=Thu Mar 02 21:07:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533156, encodeId=3dce5331563b, content=修了图片等了快一个月了也没有回复，能不能发邮件问一下<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3c485caee58448a74e2f8e0e8cd4a710.jpg, createdBy=f4421981394, createdName=lary, createdTime=Tue Feb 21 21:51:00 CST 2017, time=2017-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533070, encodeId=cdb55330e047, content=您好 请问修改后的稿件要怎么投出去？<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533069, encodeId=6ef353306939, content=您好 请问修改后的稿件怎么投出去？邮件么？<span class="quote">Dr.Q 2017-02-08 发表::<br>接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。</span>, beContent=Dr.Q 2017-02-08 发表:: 接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532807, encodeId=24aa53280e1a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86979398, createdName=jerryraincy, createdTime=Tue Feb 14 13:51:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532578, encodeId=a7125325e8e7, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e581988587, createdName=Dr.Q, createdTime=Wed Feb 08 11:13:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532564, encodeId=58ad5325643e, content=请问<span class="quote">独孤九剑 2017-02-04 发表::<br>不收病例报道</span>, beContent=独孤九剑 2017-02-04 发表:: 不收病例报道, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/27/5c1c28f375e458734b074bfcd8876252.jpg, createdBy=c3fa2014320, createdName=TanTXiangS, createdTime=Tue Feb 07 22:35:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532467, encodeId=989d53246e19, content=不收病例报道<span class="quote">langlangzhou 2017-02-03 发表::<br>各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式</span>, beContent=langlangzhou 2017-02-03 发表:: 各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ede81680471, createdName=独孤九剑, createdTime=Sat Feb 04 14:15:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532416, encodeId=f582532416a5, content=各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce51994062, createdName=langlangzhou, createdTime=Fri Feb 03 09:13:00 CST 2017, time=2017-02-03, status=1, ipAttribution=)]
    2017-02-08 Dr.Q

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=534017, encodeId=b8a453401ed7, content=还是问问吧<span class="quote">liyarui 2017-02-21 发表::<br>修了图片等了快一个月了也没有回复，能不能发邮件问一下</span>, beContent=liyarui 2017-02-21 发表:: 修了图片等了快一个月了也没有回复，能不能发邮件问一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Fri Mar 10 23:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533649, encodeId=b8dd5336497a, content=请问关于天然产物对肝癌细胞的抑制作用的文章可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb781996655, createdName=蓝莓花青素, createdTime=Thu Mar 02 21:07:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533156, encodeId=3dce5331563b, content=修了图片等了快一个月了也没有回复，能不能发邮件问一下<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3c485caee58448a74e2f8e0e8cd4a710.jpg, createdBy=f4421981394, createdName=lary, createdTime=Tue Feb 21 21:51:00 CST 2017, time=2017-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533070, encodeId=cdb55330e047, content=您好 请问修改后的稿件要怎么投出去？<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533069, encodeId=6ef353306939, content=您好 请问修改后的稿件怎么投出去？邮件么？<span class="quote">Dr.Q 2017-02-08 发表::<br>接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。</span>, beContent=Dr.Q 2017-02-08 发表:: 接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532807, encodeId=24aa53280e1a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86979398, createdName=jerryraincy, createdTime=Tue Feb 14 13:51:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532578, encodeId=a7125325e8e7, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e581988587, createdName=Dr.Q, createdTime=Wed Feb 08 11:13:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532564, encodeId=58ad5325643e, content=请问<span class="quote">独孤九剑 2017-02-04 发表::<br>不收病例报道</span>, beContent=独孤九剑 2017-02-04 发表:: 不收病例报道, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/27/5c1c28f375e458734b074bfcd8876252.jpg, createdBy=c3fa2014320, createdName=TanTXiangS, createdTime=Tue Feb 07 22:35:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532467, encodeId=989d53246e19, content=不收病例报道<span class="quote">langlangzhou 2017-02-03 发表::<br>各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式</span>, beContent=langlangzhou 2017-02-03 发表:: 各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ede81680471, createdName=独孤九剑, createdTime=Sat Feb 04 14:15:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532416, encodeId=f582532416a5, content=各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce51994062, createdName=langlangzhou, createdTime=Fri Feb 03 09:13:00 CST 2017, time=2017-02-03, status=1, ipAttribution=)]
    2017-02-07 TanTXiangS

    请问独孤九剑 2017-02-04 发表::
    不收病例报道

    独孤九剑 2017-02-04 发表:: 不收病例报道

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=534017, encodeId=b8a453401ed7, content=还是问问吧<span class="quote">liyarui 2017-02-21 发表::<br>修了图片等了快一个月了也没有回复，能不能发邮件问一下</span>, beContent=liyarui 2017-02-21 发表:: 修了图片等了快一个月了也没有回复，能不能发邮件问一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Fri Mar 10 23:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533649, encodeId=b8dd5336497a, content=请问关于天然产物对肝癌细胞的抑制作用的文章可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb781996655, createdName=蓝莓花青素, createdTime=Thu Mar 02 21:07:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533156, encodeId=3dce5331563b, content=修了图片等了快一个月了也没有回复，能不能发邮件问一下<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3c485caee58448a74e2f8e0e8cd4a710.jpg, createdBy=f4421981394, createdName=lary, createdTime=Tue Feb 21 21:51:00 CST 2017, time=2017-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533070, encodeId=cdb55330e047, content=您好 请问修改后的稿件要怎么投出去？<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533069, encodeId=6ef353306939, content=您好 请问修改后的稿件怎么投出去？邮件么？<span class="quote">Dr.Q 2017-02-08 发表::<br>接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。</span>, beContent=Dr.Q 2017-02-08 发表:: 接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532807, encodeId=24aa53280e1a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86979398, createdName=jerryraincy, createdTime=Tue Feb 14 13:51:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532578, encodeId=a7125325e8e7, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e581988587, createdName=Dr.Q, createdTime=Wed Feb 08 11:13:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532564, encodeId=58ad5325643e, content=请问<span class="quote">独孤九剑 2017-02-04 发表::<br>不收病例报道</span>, beContent=独孤九剑 2017-02-04 发表:: 不收病例报道, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/27/5c1c28f375e458734b074bfcd8876252.jpg, createdBy=c3fa2014320, createdName=TanTXiangS, createdTime=Tue Feb 07 22:35:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532467, encodeId=989d53246e19, content=不收病例报道<span class="quote">langlangzhou 2017-02-03 发表::<br>各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式</span>, beContent=langlangzhou 2017-02-03 发表:: 各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ede81680471, createdName=独孤九剑, createdTime=Sat Feb 04 14:15:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532416, encodeId=f582532416a5, content=各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce51994062, createdName=langlangzhou, createdTime=Fri Feb 03 09:13:00 CST 2017, time=2017-02-03, status=1, ipAttribution=)]
    2017-02-04 独孤九剑

    不收病例报道langlangzhou 2017-02-03 发表::
    各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式

    langlangzhou 2017-02-03 发表:: 各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=534017, encodeId=b8a453401ed7, content=还是问问吧<span class="quote">liyarui 2017-02-21 发表::<br>修了图片等了快一个月了也没有回复，能不能发邮件问一下</span>, beContent=liyarui 2017-02-21 发表:: 修了图片等了快一个月了也没有回复，能不能发邮件问一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Fri Mar 10 23:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533649, encodeId=b8dd5336497a, content=请问关于天然产物对肝癌细胞的抑制作用的文章可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb781996655, createdName=蓝莓花青素, createdTime=Thu Mar 02 21:07:00 CST 2017, time=2017-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533156, encodeId=3dce5331563b, content=修了图片等了快一个月了也没有回复，能不能发邮件问一下<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3c485caee58448a74e2f8e0e8cd4a710.jpg, createdBy=f4421981394, createdName=lary, createdTime=Tue Feb 21 21:51:00 CST 2017, time=2017-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533070, encodeId=cdb55330e047, content=您好 请问修改后的稿件要怎么投出去？<span class="quote">jerryraincy 2017-02-14 发表::<br>研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。</span>, beContent=jerryraincy 2017-02-14 发表:: 研究方向：肝癌;转移; 接收率：约50% 审稿时间：约2个月 该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533069, encodeId=6ef353306939, content=您好 请问修改后的稿件怎么投出去？邮件么？<span class="quote">Dr.Q 2017-02-08 发表::<br>接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。</span>, beContent=Dr.Q 2017-02-08 发表:: 接收率：约50% 审稿时间：约2个月 杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Mon Feb 20 00:33:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532807, encodeId=24aa53280e1a, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：该文章IF比较低，整体接收率还不错，前后大概3个月多accepted，但是等proof时间比较久。且审稿意见比较多，而且版面费不便宜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c86979398, createdName=jerryraincy, createdTime=Tue Feb 14 13:51:00 CST 2017, time=2017-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532578, encodeId=a7125325e8e7, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：杂志初审很快1.5个月左右，接收也比较快，就是等proof时间长一点，另外稿费比较高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e581988587, createdName=Dr.Q, createdTime=Wed Feb 08 11:13:00 CST 2017, time=2017-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532564, encodeId=58ad5325643e, content=请问<span class="quote">独孤九剑 2017-02-04 发表::<br>不收病例报道</span>, beContent=独孤九剑 2017-02-04 发表:: 不收病例报道, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/02/27/5c1c28f375e458734b074bfcd8876252.jpg, createdBy=c3fa2014320, createdName=TanTXiangS, createdTime=Tue Feb 07 22:35:00 CST 2017, time=2017-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532467, encodeId=989d53246e19, content=不收病例报道<span class="quote">langlangzhou 2017-02-03 发表::<br>各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式</span>, beContent=langlangzhou 2017-02-03 发表:: 各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ede81680471, createdName=独孤九剑, createdTime=Sat Feb 04 14:15:00 CST 2017, time=2017-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532416, encodeId=f582532416a5, content=各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cce51994062, createdName=langlangzhou, createdTime=Fri Feb 03 09:13:00 CST 2017, time=2017-02-03, status=1, ipAttribution=)]
    2017-02-03 langlangzhou

    各位大侠，我是第一次投英文杂志，每个杂志的格式都不一样，怎样知道这个杂志的格式，尤其是病例报道的格式

    0

共500条页码: 36/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分